Yueming Ma

3.0k total citations · 1 hit paper
111 papers, 2.4k citations indexed

About

Yueming Ma is a scholar working on Pharmacology, Molecular Biology and Pharmacology. According to data from OpenAlex, Yueming Ma has authored 111 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Pharmacology, 38 papers in Molecular Biology and 35 papers in Pharmacology. Recurrent topics in Yueming Ma's work include Traditional Chinese Medicine Analysis (27 papers), Drug Transport and Resistance Mechanisms (26 papers) and Pharmacological Effects of Natural Compounds (25 papers). Yueming Ma is often cited by papers focused on Traditional Chinese Medicine Analysis (27 papers), Drug Transport and Resistance Mechanisms (26 papers) and Pharmacological Effects of Natural Compounds (25 papers). Yueming Ma collaborates with scholars based in China, United States and Hong Kong. Yueming Ma's co-authors include Bing‐Liang Ma, Tianming Wang, Rong Shi, Jiasheng Wu, Changhong Wang, Bing Wang, Miao Zhang, Ning Zhang, Lei Pan and Dongming Yan and has published in prestigious journals such as Nature Communications, Gastroenterology and PLoS ONE.

In The Last Decade

Yueming Ma

109 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases

2023 239 citations Miao Zhang, Yueming Ma et al. Signal Transduction and Targeted Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yueming Ma China	29	1.0k	850	545	389	335	111	2.4k
Xiaodong Liu China	30	1.1k 1.1×	736 0.9×	626 1.1×	215 0.6×	1.0k 3.0×	164	3.1k
Huidi Jiang China	32	1.3k 1.3×	536 0.6×	449 0.8×	316 0.8×	661 2.0×	145	3.2k
Shu-Feng Zhou China	33	1.3k 1.3×	848 1.0×	492 0.9×	426 1.1×	500 1.5×	66	3.3k
Yuqi He China	26	1.2k 1.2×	525 0.6×	439 0.8×	194 0.5×	353 1.1×	132	2.3k
Sakae Amagaya Japan	33	1.4k 1.4×	864 1.0×	439 0.8×	388 1.0×	249 0.7×	86	2.9k
Yanling Zhao China	22	848 0.8×	441 0.5×	244 0.4×	274 0.7×	154 0.5×	76	1.9k
Seyed Mohammad Nabavi Iran	26	1.3k 1.3×	432 0.5×	467 0.9×	384 1.0×	206 0.6×	31	3.6k
Fen‐Pi Chou Taiwan	31	1.1k 1.1×	888 1.0×	418 0.8×	268 0.7×	324 1.0×	62	3.0k
Shikai Yan China	29	1.8k 1.8×	669 0.8×	347 0.6×	668 1.7×	127 0.4×	138	3.0k
Mao‐Jung Lee United States	31	1.0k 1.0×	567 0.7×	219 0.4×	290 0.7×	391 1.2×	52	4.3k

Countries citing papers authored by Yueming Ma

Since Specialization

Citations

This map shows the geographic impact of Yueming Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yueming Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yueming Ma more than expected).

Fields of papers citing papers by Yueming Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yueming Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yueming Ma. The network helps show where Yueming Ma may publish in the future.

Co-authorship network of co-authors of Yueming Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Yueming Ma. A scholar is included among the top collaborators of Yueming Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yueming Ma. Yueming Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ma, Yueming, et al.. (2025). From neuromodulation to bone homeostasis: therapeutic targets of nerve growth factor in skeletal diseases. Frontiers in Pharmacology. 16. 1614542–1614542.

Ma, Yueming, et al.. (2025). Fatigue crack resistance and lifetime comparison of newly-developed DZ2 axle steel with standard EA4T alloy material. Engineering Failure Analysis. 182. 110019–110019.

Meng, Qian, Hongwen Zhu, Yuanyuan Li, et al.. (2024). Quantitative proteomics reveals the protective effects of Yinchenzhufu decoction against cholestatic liver fibrosis in mice by inhibiting the PDGFRβ/PI3K/AKT pathway. Frontiers in Pharmacology. 15. 1341020–1341020. 4 indexed citations

Zhang, Miao, et al.. (2023). TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases. Signal Transduction and Targeted Therapy. 8(1). 261–261. 239 indexed citations breakdown →

Zhang, Jieyu, Yan Chen, Wenxiang Fan, et al.. (2023). Study on herb-herb interaction between active components of Plantago asiatica L. seed and Coptis chinensis Franch. rhizoma based on transporters using UHPLC-MS/MS. Journal of Pharmaceutical and Biomedical Analysis. 227. 115234–115234. 1 indexed citations

Wang, Tianming, Yuanyuan Li, Juan Zou, et al.. (2022). Gardenia jasminoides Ellis polysaccharide ameliorates cholestatic liver injury by alleviating gut microbiota dysbiosis and inhibiting the TLR4/NF-κB signaling pathway. International Journal of Biological Macromolecules. 205. 23–36. 81 indexed citations

Li, Yuanyuan, Hua Zhang, Leilei Zhu, et al.. (2021). Pharmacokinetics-based comprehensive strategy to identify multiple effective components in Huangqi decoction against liver fibrosis. Phytomedicine. 84. 153513–153513. 29 indexed citations

Zheng, Min, Jiasheng Wu, Hongyu Li, et al.. (2020). Da-Huang-Xiao-Shi decoction protects against3, 5-diethoxycarbonyl-1,4-dihydroxychollidine-induced chronic cholestasis by upregulating bile acid metabolic enzymes and efflux transporters. Journal of Ethnopharmacology. 269. 113706–113706. 12 indexed citations

Zhong, Yifei, Kyung Lee, Yueming Ma, et al.. (2019). Arctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes. Nature Communications. 10(1). 4523–4523. 123 indexed citations

10.

Jin, Jingyi, et al.. (2019). Simultaneous determination of multiple compounds of Da-Huang-Xiao-Shi decoction in rat plasma by LC-MS/MS and its application in a pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 174. 8–18. 10 indexed citations

11.

Gu, Ming, Jinwen Huang, Yuanyuan Zhao, et al.. (2016). Silymarin Ameliorates Metabolic Dysfunction Associated with Diet-Induced Obesity via Activation of Farnesyl X Receptor. Frontiers in Pharmacology. 7. 345–345. 62 indexed citations

12.

Wang, Qian, Peng Jiang, Rong Shi, et al.. (2014). Identification and pharmacokinetics of multiple constituents in rat plasma after oral administration of Yinchenzhufu decoction. Journal of Ethnopharmacology. 153(3). 714–724. 13 indexed citations

13.

Wu, Jiasheng, Yuan Liu, Rong Shi, et al.. (2014). Effects of combinations of Xiexin decoction constituents on diabetic nephropathy in rats. Journal of Ethnopharmacology. 157. 126–133. 20 indexed citations

14.

Zhong, Jie, Rong Shi, Xinhong Wang, et al.. (2013). Relationships between pharmacokinetics and efficacy of Xie-xin decoction in rats with experimental ulcerative colitis. Journal of Ethnopharmacology. 148(1). 182–189. 21 indexed citations

15.

Ma, Bing‐Liang, et al.. (2011). Influences of Fructus evodiae pretreatment on the pharmacokinetics of Rhizoma coptidis alkaloids. Journal of Ethnopharmacology. 137(3). 1395–1401. 13 indexed citations

16.

Wang, Changhong, Yan Li, Yuqi He, et al.. (2011). The comparative pharmacokinetics of two pyrrolizidine alkaloids, senecionine and adonifoline, and their main metabolites in rats after intravenous and oral administration by UPLC/ESIMS. Analytical and Bioanalytical Chemistry. 401(1). 275–287. 34 indexed citations

17.

Shi, Rong, et al.. (2010). Simultaneous quantification of multiple active components from Xiexin decoction in rat plasma by LC‐ESI‐MS/MS: application in pharmacokinetics. Biomedical Chromatography. 25(7). 816–826. 31 indexed citations

18.

Ma, Yueming. (2010). Research progress in rhubarb polysaccharides. Zhongguo xin yao zazhi. 1 indexed citations

19.

Qiu, Furong, Guangji Wang, Rong Zhang, et al.. (2010). Effect of danshen extract on the activity of CYP3A4 in healthy volunteers. British Journal of Clinical Pharmacology. 69(6). 656–662. 30 indexed citations

20.

Chen, Yingrong, Yueming Ma, & Wei Ma. (2009). Pharmacokinetics and bioavailability of cinnamic acid after oral administration of ramulus cinnamomi in rats. European Journal of Drug Metabolism and Pharmacokinetics. 34(1). 51–56. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact